13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001892770
Total reported value
$189.2M
$189.2M
87 檔
64.3%
During the Q4 2025 filing period, Knott David M Jr (CIK: 0001892770) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $189.2M across 87 reported positions.
Knott David M Jr executed strategic sector rebalancing during Q4 2025, establishing 13 new positions while fully exiting 14 holdings and trimming 20 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLMT | Calumet Inc | Stock-Other | 20.38% | — | -21.60% | |
| 2 | APO | Apollo Global Management Inc | Stock-Financials | 15.08% | -0.85% | — | |
| 3 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 13.28% | +1.46% | -18.54% | |
| 4 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 4.04% | -0.82% | -3.04% | |
| 5 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 3.53% | +0.78% | -4.43% | |
| 6 | TVTX | Travere Therapeutics Inc | Stock-Other | 3.29% | +1.93% | -28.46% | |
| 7 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 3.01% | -0.32% | — | |
| 8 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 2.95% | +0.13% | -12.05% | |
| 9 | JPM | Jpmorgan Chase & Co | Stock-Financials | 2.91% | -0.28% | -4.40% | |
| 10 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 2.19% | -0.30% | -78.63% | |
| 11 | VRDN | Viridian Therapeutics Inc | Stock-Other | 2.09% | -0.35% | +24.38% | |
| 12 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 2.04% | -1.77% | EXIT | |
| 13 | COGT | Cogent Biosciences Inc | Stock-Other | 1.68% | -0.11% | — | |
| 14 | RCUS | Arcus Biosciences Inc | Stock-Other | 1.34% | +0.28% | +27.35% | |
| 15 | ALKS | Alkermes plc | Stock-Healthcare | 1.23% | +0.84% | +392.23% | |
| 16 | DCGO | Docgo Inc | Stock-Other | 1.09% | -0.27% | -13.03% | |
| 17 | HELP | Cybin Inc | Stock-Other | 1.08% | +0.29% | +103.35% | |
| 18 | CYTK | Cytokinetics Inc | Stock-Healthcare | 1.00% | -0.93% | EXIT | |
| 19 | ATRC | Atricure Inc | Stock-Other | 0.94% | -0.11% | +7.08% | |
| 20 | AB | Alliancebernstein Holding LP | Stock-Other | 0.86% | -0.18% | — | |
| 21 | ✓ | Stock-Other | 0.78% | — | — | ||
| 22 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 0.73% | +0.11% | +160.00% | |
| 23 | TECX | Tectonic Therapeutic Inc | Stock-Other | 0.71% | — | — | |
| 24 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.71% | -0.05% | — | |
| 25 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.66% | -0.06% | — | |
| 26 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 0.62% | +0.16% | — | |
| 27 | VERA | Vera Therapeutics Inc | Stock-Other | 0.61% | -0.03% | — | |
| 28 | CLOZ | Eldridge Bbb-b Clo ETF | ETF-Other | 0.59% | -0.06% | — | |
| 29 | BHVN | Biohaven Ltd. | Stock-Other | 0.58% | — | — | |
| 30 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.55% | -0.43% | -18.52% | |
| 31 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.54% | +0.23% | — | |
| 32 | ADMA | Adma Biologics Inc | Stock-Healthcare | 0.51% | -0.32% | EXIT | |
| 33 | BIIB | Biogen Inc | Stock-Healthcare | 0.49% | +0.02% | +200.00% | |
| 34 | OBIO | Orchestra Biomed Holdings In | Stock-Other | 0.48% | -0.06% | +28.21% | |
| 35 | IBB | Ishares Biotechnology ETF | ETF-Tech | 0.43% | — | +22.22% | |
| 36 | SLDB | Solid Biosciences Inc | Stock-Other | 0.42% | +0.10% | — | |
| 37 | LENZ | Lenz Therapeutics Inc | Stock-Other | 0.40% | -0.18% | EXIT | |
| 38 | PFE | Pfizer Inc | Stock-Healthcare | 0.37% | -0.13% | -56.62% | |
| 39 | RZLT | Rezolute Inc | Stock-Other | 0.37% | +0.35% | +23.64% | |
| 40 | MSFT | Microsoft CORP | Stock-Tech | 0.36% | -0.03% | — | |
| 41 | AAPL | Apple Inc | Stock-Tech | 0.31% | — | — | |
| 42 | ✓ | Stock-Other | 0.31% | — | — | ||
| 43 | NKTR | Nektar Therapeutics | Stock-Other | 0.30% | — | — | |
| 44 | IBM | Intl Business Machines CORP | Stock-Tech | 0.29% | +0.01% | — | |
| 45 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.28% | — | +54.59% | |
| 46 | PTHS | Pelthos Therapeutics Inc | Stock-Other | 0.28% | +0.07% | +215.46% | |
| 47 | CNQ | Canadian Natural Resources | Stock-Energy | 0.26% | -0.14% | — | |
| 48 | ✓ | Connect Biopharma Hldgs LTD | Stock-Other | 0.26% | -0.04% | — | |
| 49 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.23% | — | — | |
| 50 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 0.23% | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | APO | Apollo Global Management Inc | +3% | — | Unchanged |
| 2 | GOOG | Alphabet Inc-cl C | +2.3% | -18.54% | Trim |
| 3 | SNDX | Syndax Pharmaceuticals Inc | +1.4% | -3.04% | Trim |
| 4 | BBIO | Bridgebio Pharma Inc | +1.2% | — | Unchanged |
| 5 | VRDN | Viridian Therapeutics Inc | +1.1% | +24.38% | Add |
| 6 | ALKS | Alkermes plc | +1% | +392.23% | Add |
| 7 | RCUS | Arcus Biosciences Inc | +0.8% | +27.35% | Add |
| 8 | TVTX | Travere Therapeutics Inc | +0.8% | -28.46% | Trim |
| 9 | HELP | Cybin Inc | +0.8% | +103.35% | Add |
| 10 | PTGX | Protagonist Therapeutics Inc | +0.7% | -12.05% | Trim |
| 11 | CPRX | Catalyst Pharmaceuticals Inc | +0.5% | — | Unchanged |
| 12 | XBI | Ss Spdr S&p Biotech ETF | +0.5% | +160.00% | Add |
| 13 | WVE | Wave Life Sciences Ltd. | +0.4% | — | Unchanged |
| 14 | BIIB | Biogen Inc | +0.4% | +200.00% | Add |
| 15 | CYTK | Cytokinetics Inc | +0.3% | +13.33% | Add |
| 16 | JPM | Jpmorgan Chase & Co | +0.3% | -4.40% | Trim |
| 17 | VERA | Vera Therapeutics Inc | +0.3% | — | Unchanged |
| 18 | OBIO | Orchestra Biomed Holdings In | +0.3% | +28.21% | Add |
| 19 | ATRC | Atricure Inc | +0.3% | +7.08% | Add |
| 20 | TECX | Tectonic Therapeutic Inc | +0.2% | — | Unchanged |
| 21 | PTHS | Pelthos Therapeutics Inc | +0.2% | +215.46% | Add |
| 22 | XERS | Xeris Biopharma Holdings Inc | +0.2% | -4.43% | Trim |
| 23 | IBB | Ishares Biotechnology ETF | +0.2% | +22.22% | Add |
| 24 | MDGL | Madrigal Pharmaceuticals Inc | +0.2% | — | Unchanged |
| 25 | SRRK | Scholar Rock Holding CORP | +0.1% | +54.59% | Add |
| 26 | JNJ | Johnson & Johnson | +0.1% | — | Unchanged |
| 27 | AB | Alliancebernstein Holding LP | +0.1% | — | Unchanged |
| 28 | IVVD | Invivyd Inc | +0.1% | — | Unchanged |
| 29 | CLOZ | Eldridge Bbb-b Clo ETF | +0.1% | — | Unchanged |
| 30 | BMY | Bristol-myers Squibb Co | +0.1% | -18.52% | Trim |
| 31 | XENE | Xenon Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 32 | AAPL | Apple Inc | +0.1% | — | Unchanged |
| 33 | IBM | Intl Business Machines CORP | +0.1% | — | Unchanged |
| 34 | CNQ | Canadian Natural Resources | 0% | — | Unchanged |
| 35 | MSFT | Microsoft CORP | 0% | — | Unchanged |
| 36 | SLDB | Solid Biosciences Inc | 0% | — | Unchanged |
| 37 | AVGO | Broadcom Inc | 0% | — | Unchanged |
| 38 | ✓ | 0% | — | Unchanged | |
| 39 | DHR | Danaher CORP | 0% | — | Unchanged |
| 40 | ✓ | 0% | — | Unchanged | |
| 41 | NVDA | Nvidia CORP | 0% | — | Unchanged |
| 42 | LEGH | Legacy Housing CORP | — | — | Unchanged |
| 43 | URI | United Rentals Inc | — | — | Unchanged |
| 44 | TMO | Thermo Fisher Scientific Inc | — | — | Unchanged |
| 45 | AMZN | Amazon.com Inc | — | — | Unchanged |
| 46 | OXY | Occidental Petroleum CORP | — | — | Unchanged |
| 47 | CRM | Salesforce Inc | — | — | Unchanged |
| 48 | KD | Kyndryl Holdings Inc | — | — | Unchanged |
| 49 | EBC | Eastern Bankshares Inc | — | — | Unchanged |
| 50 | PWR | Quanta Services Inc | — | — | Unchanged |
According to official SEC Form 13F filings, Knott David M Jr reported a total U.S. public equity portfolio value of $189.2M across 87 disclosed positions in Q4 2025.
During Q4 2025, Knott David M Jr's top holdings by market value included CLMT (20.4%)、APO (15.1%)、GOOG (13.3%). The largest single position, CLMT, represented 20.4% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including CLMT, APO, GOOG) accounted for 64.3% of total reported equity market value during Q4 2025.
Top New Position Initiated
COGT
市值: $3.6M
Top Position Liquidated / Trimmed
DAR
前期市值: $9.3M
In Q4 2025, Knott David M Jr made 62 total portfolio adjustments, initiating 13 new buys, adding to 15 positions, trimming 20 holdings, and fully liquidating 14 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.